Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006

American Journal of Hematology

Volumn 85, Issue 10, 2010, Pages 765-770

  De Roos, Anneclaire J ^a,b   Deeg, H Joachim ^a   Onstad, Lynn ^a   Kopecky, Kenneth J ^a,b   Aiello Bowles, Erin J ^c   Yong, Mellissa ^d   Fryzek, Jon ^d   Davis, Scott ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTER FOR HEALTH STUDIES   (United States)

^d AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; DIABETES MELLITUS; DISEASE SURVEILLANCE; FEMALE; HEALTH CARE SYSTEM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANDATORY REPORTING; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MYELODYSPLASTIC SYNDROME; NON PROFIT ORGANIZATION; PATIENT CODING; PATIENT IDENTIFICATION; PRIORITY JOURNAL; UNITED STATES; AGE DISTRIBUTION; BLOOD CELL COUNT; COMORBIDITY; COMPARATIVE STUDY; ELECTRONIC MEDICAL RECORD; FACTUAL DATABASE; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; INTERNATIONAL CLASSIFICATION OF DISEASES; MYELODYSPLASTIC SYNDROMES; ORGANIZATION AND MANAGEMENT; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; BLOOD CELL COUNT; COMORBIDITY; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE, INTEGRATED; HUMANS; INCIDENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MYELODYSPLASTIC SYNDROMES; ORGANIZATIONS, NONPROFIT; REPRODUCIBILITY OF RESULTS; SEER PROGRAM; WASHINGTON;

EID: 77957659799     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21828     Document Type: Article

References (16)

1. Schumacher HR, Nand S. Myelodysplastic Syndromes: Approach to Diagnosis and Treatment. New York: IGAKU-SHOIN Medical Publishers; 1995.
2. Steensma DP, Bennett JM. The myelodysplastic syndromes: Diagnosis and treatment. Mayo Clin Proc 2006;81:104-130.
3. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization; 2000.
4. Raza A, Mundle SD. Myelodysplastic Syndromes and Secondary Acute Myelogenous Leukemia: Directions for the New Millennium. Boston: Kluwer Academic Publishers; 2001.
5. Sandhu SK, Sekeres MA. Myelodysplastic syndromes: More prevalent than we know. Geriatrics 2008;63:10-17.
6. American Cancer Society. Detailed Guide: Myelodysplastic Syndrome. What Are the Key Statistics About Myelodysplastic Syndromes? American Cancer Society; 2005. Available on: http://www.cancer.org/cancer/myelodysplasticsyndrome/ detailedguide/myelodysplastic-syndromes-key-statistics.
7. Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008;112:45-52.
8. Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: Incidence and survival in the United States. Cancer 2007;109:1536-1542.
9. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer. cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Research Data, Nov 2009 Sub (1973-2007) 〈Katrina/Rita Population Adjustment〉-Linked To County Attributes-Total U.S., 1969-2007 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission.
10. World Health Organization. Classification of Tumours, Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
11. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-199.
12. Williamson PJ, Kruger AR, Reynolds PJ, et al. Establishing the incidence of myelodysplastic syndrome. Br J Haematol 1994;87:743-745.
13. De Roos AJ, Deeg HJ, Davis S. A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): Impact of type and treatment of primary cancers. Cancer Causes Control 2007;18:1199-1208.
14. Sekeres MA, Schoonen WM, Kantarjian H, et al. Characteristics of US patients with myelodysplastic syndromes: Results of six cross-sectional physician surveys. J Natl Cancer Inst 2008;100:1542-1551.
15. US Census Bureau. Census 2000 Summary File 1-Washington State. Available at: http://www2.census.gov/census-2000/datasets/Summary-File-1/Washington/, Washington, DC, 2002.
16. National Cancer Institute. The HMO Cancer Research Network (CRN): Capacity, Collaboration, and Investigation. Bethesda, MD: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services; 2010.